Results 71 to 80 of about 7,348 (201)

Mesalamine-induced photosensitivity – A case report and literature review

, 2023
Svetlana Popadić, Igor Kapetanović, Aleksandra Sokic‐Milutinovic   +2 more
openalex   +1 more source

A hydrogen-sulfide derivative of mesalamine reduces the severity of intestinal and lung injury in necrotizing enterocolitis through endothelial nitric oxide synthase

, 2022
Brian D. Hosfield, Chelsea Hunter, Hongge Li, Natalie A. Drucker, Anthony R. Pecoraro, Krishna Manohar, W. Christopher Shelley, Troy A. Markel   +7 more
openalex   +2 more sources

Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials

Drug Design, Development and Therapy, 2014
David Pierce,1 Mary Corcoran,2 Patrick Martin,2 Karen Barrett,1 Susi Inglis,1 Peter Preston,2 Thomas N Thompson,3 Sandra K Willsie3 1Shire, Basingstoke, UK; 2Shire, Wayne, PA, USA; 3PRA International, Lenexa, KS, USA Background: MMX® mesalamine is a
Pierce D, Corcoran M, Martin P, Barrett K, Inglis S, Preston P, Thompson TN, Willsie SK   +7 more
doaj  

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis [PDF]

, 2008
Michael A. Kamm, Gary R. Lichtenstein, William J. Sandborn, Stefan Schreiber, Kirstin Lees, Karen Barrett, Raymond E. Joseph   +6 more
openalex   +1 more source

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease

JGH Open, 2019
Background and Aim The literature on medication adherence in patients with inflammatory bowel disease (IBD) is heterogeneous. The present study aimed to identify the rates and predictors of nonadherence to medications in IBD. Methods This cross‐sectional
Sanjeevani K Tomar, Saurabh Kedia, Namrata Singh, Ashish D Upadhyay, Nagesh Kamat, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Saransh Jain, Govind Makharia, Vineet Ahuja   +10 more
doaj   +1 more source

Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission [PDF]

, 2015
Gary R. Lichtenstein, Glenn L. Gordon, Salam Zakko, Uma K. Murthy, Shahriar Sedghi, Ron E. Pruitt, Andrew C. Barrett, Enoch Bortey, Craig Paterson, William P. Forbes   +9 more
openalex   +1 more source

A rare case of mesalamine-induced eosinophilic pleural effusion

The Journal of Association of Chest Physicians
We present a very rare case of a 47-year-old man with a history of ulcerative colitis (UC), referred to as a case of an undiagnosed bilateral pleural effusion.
Ankit Bhatia, Sharad Joshi, Nitesh Tayal, Maj Gen Darshan Singh Bhakuni, Subhasish Majumdar   +4 more
doaj   +1 more source

Endoscopic and clinicopathological features of segmental colitis associated with diverticulosis

DEN Open
Objectives Segmental colitis associated with diverticulosis (SCAD) has close endoscopic and pathological similarities to ulcerative colitis (UC) and Crohn's disease. Clinical data on SCAD are limited in Japan.
Kazuhiko Obata, Kan Uchiyama, Ryuzo Murai   +2 more
doaj   +1 more source

Mesalamine-Induced Myocarditis and Coronary Vasculitis in a Pediatric Ulcerative Colitis Patient: A Case Report

Case Reports in Pediatrics, 2011
Mesalamine-containing products are often a first-line treatment for ulcerative colitis. Severe adverse reactions to these products, including cardiovascular toxicity, are rarely seen in pediatric patients.
Elimarys Perez-Colon, Gul H. Dadlani, Ivan Wilmot, Michelle Miller   +3 more
doaj   +1 more source

Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study [PDF]

, 2010
Hiroaki Ito, Mitsuo Iida, Takayuki Matsumoto, Yasuo Suzuki, Hidetaka Sasaki, Toyomitsu Yoshida, Yuichi Takano, Toshifumi Hibi∥   +7 more
openalex   +1 more source